TLDR Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.
The document reviewed studies identifying stroke risk factors unique to women, emphasizing the influence of sex hormones, reproductive history, and hormonal contraceptive use. Elevated estradiol and low dehydroepiandrosterone sulfate levels were linked to increased ischemic stroke risk in postmenopausal women. Early menarche, early menopause, hormone replacement therapy, pregnancy, and the postpartum period were significant risk factors. The findings highlighted the need for gender-specific strategies in stroke prevention and management, including tailored healthcare guidelines for women.
14 citations,
September 2017 in “Clinics in Dermatology” Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.
254 citations,
September 2014 in “Menopause” The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.
21 citations,
March 2019 in “Critical Reviews in Clinical Laboratory Sciences” The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.
34 citations,
June 2010 in “Archives of Disease in Childhood” Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.
359 citations,
September 2017 in “European Journal of Epidemiology” The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.
